Eltrombo-50

Eltrombo-50

Composition: Eltrombopag Olamine – 50 mg

Therapeutic Class: Thrombopoietin Receptor Agonist

Eltrombo: Restore the Falling Platelet Count

Eltrombo is widely accepted by doctors and frequently used as supportive care in cancer treatments before or after chemotherapy.

Aprazer Healthcare: Leading Oncology Medicine Manufacturer

Aprazer Healthcare manufactures a wide range of affordable oncology medicines available in 50+ countries including South America, Southeast Asia, Africa, and the CIS region.

What is Eltrombo?

Eltrombo is used as an adjuvant to chemotherapy or other chronic treatments, in which the platelet count falls severely.

Uses of Eltrombo

It is used as a supportive treatment in:

• • Chronic HCV infections
• • Immune Thrombocytopenic Purpura (ITP)
• • Bone Marrow suppression causing severe aplastic anemia

How does Eltrombo work?

Eltrombopag activates the platelet-producing receptor, increasing the platelet count.

Common Side Effects of Eltrombo

• • Tiredness
• • Pain in the abdomen
• • Changes in urine color
• • Skin rashes
• • Cough
• • Vomiting
• • Nausea

Serious Side Effects

• • Hepatotoxicity – Elevated liver enzymes
• • Thrombosis and stroke- excess platelets cause a blockade
• • Cataract Formation

Contraindications

Not to be used in patients

• • Hypersensitivity or allergic reaction to the drug or its excipients
• • Breastfeeding mothers
• • Pregnant women

Precautions

To be used cautiously in patients with:

• • Liver dysfunction or cirrhosis
• • In Cardiac patients, it may increase the risk of stroke, thromboembolic events
• • Renal impaired functions
• • Hematological disorders

Warnings

• • Prescription drug to be used under medical supervision.
• • Not recommended in Myelodysplastic Syndromes (MDS)

Important Safety and Monitoring Information

• • Monitor for Hepatotoxicity
• • Liver function tests
• • Regular CBC- platelet count
• • Cardiac functions- thromboembolic events due to overproduction of platelets
• • Ophthalmic functions